PART I Overview Our mission is to build a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. We have developed, licensed, and acquired a portfolio of meaningfully differentiated products for use in the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. We commercialize our products, consisting of Jornay PM, Belbuca, Xtampza ER, Nucynta ER and Nucynta IR (collectively the Nucynta ...
Q2 FY2026 — expected 2026-08-10
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001628280-26-011992 | EDGAR | 75K words |
| 2025-02-27 | 2024-12-31 | 0001558370-25-001801 | EDGAR | — |
| 2024-02-22 | 2023-12-31 | 0001558370-24-001526 | EDGAR | — |
| 2023-02-23 | 2022-12-31 | 0001558370-23-001900 | EDGAR | — |
| 2022-02-24 | 2021-12-31 | 0001558370-22-001927 | EDGAR | — |
| 2021-02-25 | 2020-12-31 | 0001558370-21-001814 | EDGAR | — |
| 2020-02-27 | 2019-12-31 | 0001558370-20-001625 | EDGAR | — |
| 2019-02-27 | 2018-12-31 | 0001558370-19-001187 | EDGAR | — |
| 2018-03-07 | 2017-12-31 | 0001558370-18-001644 | EDGAR | — |
| 2017-03-10 | 2016-12-31 | 0001558370-17-001629 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-06 | 2026-06-30 | 0001628280-26-053851 | EDGAR | — |
| 2025-11-06 | 2025-09-30 | 0001104659-25-107391 | EDGAR | 48K words |
| 2025-08-07 | 2025-06-30 | 0001558370-25-010649 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0001558370-25-006960 | EDGAR | — |
| 2024-11-07 | 2024-09-30 | 0001558370-24-014858 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0001558370-24-011586 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0001558370-24-007601 | EDGAR | — |
| 2023-11-07 | 2023-09-30 | 0001558370-23-017983 | EDGAR | — |
| 2023-08-03 | 2023-06-30 | 0001558370-23-013192 | EDGAR | — |
| 2023-05-04 | 2023-03-31 | 0001558370-23-008087 | EDGAR | — |
| 2022-11-03 | 2022-09-30 | 0001558370-22-016241 | EDGAR | — |
| 2022-08-04 | 2022-06-30 | 0001558370-22-012184 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-06 | 0001628280-26-053849 | EDGAR | — |
| 2026-03-19 | 0001104659-26-032166 | EDGAR | 52K words |
| 2026-02-26 | 0001628280-26-011990 | EDGAR | — |
| 2026-01-08 | 0001104659-26-001953 | EDGAR | — |
| 2025-12-30 | 0001104659-25-125026 | EDGAR | — |
| 2025-11-06 | 0001104659-25-107389 | EDGAR | — |
| 2025-08-07 | 0001558370-25-010647 | EDGAR | — |
| 2025-07-07 | 0001104659-25-065981 | EDGAR | — |
| 2025-05-19 | 0001104659-25-050435 | EDGAR | — |
| 2025-05-12 | 0001104659-25-047040 | EDGAR | — |
187 total filings indexed. 155 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001267565 |
| Ticker | COLL |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | VA |
| Website | https://www.collegiumpharma.com |
| Listed | 2015-05-07 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/COLL (~200 tokens, structured JSON with cryptographic provenance)